Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Brain Waves Ethical Guest Bloggers (Part 2) | Main | The Neurotechnology Wave (2010-2060) »

July 24, 2003

Passing the Goal Line in Style

Email This Entry

Posted by Zack Lynch

IPass, provider of Internet connectivity services, went public today at $14/share nine years after it's founding.  Massive congratulations to my brother Chris Lynch who was the first employee.  A veteran of several technology start ups myself, I know how critical the first hire is in setting the tone, energy and momentum for the company's first few years.  Apparently, Chris did his job well.  Also a Happy Birthday to Chris Moore today, IPass' founder.  I know what song they'll be playing a his birthday party tonight.....Prince's 1982 classic, 1999!

Comments (0) | Category: X-tra



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives